Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
SGLT2 inhibitors (also called gliflozins or flozins) are a class of medications that inhibit sodium-glucose transport proteins in the nephron (the functional units of the kidney), unlike SGLT1 inhibitors that perform a similar function in the intestinal mucosa. The foremost metabolic effect of this is to inhibit reabsorption of glucose in the kidney and…
Applications, Research, Members & Measurement
Explore the main themes, entities and connections around SGLT2 inhibitor. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
sglt2 diabetes inhibitors glucose fda approved gliflozins dapagliflozin canagliflozin risk blood type sugar kidney drug medications empagliflozin patients brand class
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| sulfonylureas | instance of | Using gliflozins in combination therapy with metformin can lower the risk of hypoglycemia compared to other type 2 diabetes treatments | 0.80 | text |
| insulin.Increased risk of lower limb amputation is associated with canagliflozin | instance of | Using gliflozins in combination therapy with metformin can lower the risk of hypoglycemia compared to other type 2 diabetes treatments | 0.80 | text |
| but further data is needed to confirm this risk associated with different gliflozins | instance of | Using gliflozins in combination therapy with metformin can lower the risk of hypoglycemia compared to other type 2 diabetes treatments | 0.80 | text |
| natriuresis | instance of | Pleiotropic effects of this class have been attributed to a variety of its pharmacodynamic actions | 0.80 | text |
| hemoconcentration | instance of | Pleiotropic effects of this class have been attributed to a variety of its pharmacodynamic actions | 0.80 | text |
| deactivation of renin | instance of | Pleiotropic effects of this class have been attributed to a variety of its pharmacodynamic actions | 0.80 | text |
| SGLT2 inhibitor | has effect | Genital | 0.60 | section |
| SGLT2 inhibitor | has effect | In | 0.60 | section |
| SGLT2 inhibitor | has effect | In May | 0.60 | section |
| SGLT2 inhibitor | has effect | FDA | 0.60 | section |
| SGLT2 inhibitor | has effect | DKA | 0.60 | section |
| SGLT2 inhibitor | has effect | By | 0.60 | section |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.